1例肝硬化失代偿期合并糖尿病痛性神经病变患者疼痛用药分析及药学监护  

Medication Analysis and Pharmaceutical Care for Pain Management in Patients with Decompensated Cirrhosis and Diabetic Painful Neuropathy

作　　者：刘清茹 欧阳文鹃 王敏[2] 唐翎[3] 肖幸华 贺蕾艳[1] Liu Qingru;Ouyang Wenjuan;Wang Min;Tang Ling;Xiao Xinghua;He Leiyan(Department of Pharmacy,Xiangya Changde Hospital,Changde 415000,Hunan,China;Department of Endocrine,Xiangya Hospital Central South University;Department of Pharmacy,Xiangya Hospital Central South University)

机构地区：[1]湘雅常德医院药剂科,湖南常德415000 [2]中南大学湘雅医院内分泌科 [3]中南大学湘雅医院药学部

出　　处：《药物流行病学杂志》2020年第10期696-699,共4页Chinese Journal of Pharmacoepidemiology

摘　　要：本文报道临床药师根据自身药学特长为医生找出可疑致不良反应的药物,并以糖尿病痛性神经病变相关指南及药物说明书、药物代谢动力学等为参考,结合1例肝硬化失代偿期合并糖尿病痛性神经病变患者实际病情,分析患者疼痛管理治疗药物的适宜性,给予个体化药物治疗方案的建议。临床药师参与临床治疗,为医生提供药学信息,优化药物治疗方案,为患者提供药学服务,保证用药安全性和有效性,为促进临床合理用药发挥了积极作用。Clinical pharmacists provided doctors with suspicious drug that cause adverse reactions based on their own pharmacological expertise, and referred to the relevant guidelines for diabetic painful neuropathy, drug instructions, pharmacokinetics, etc., and combined the actual medical history of a patient with decompensated cirrhosis and diabetic painful neuropathy, analyzed the suitability of patients’ pain management and treatment drugs, and gived recommendations for individualized drug treatment plan. The participation of clinical pharmacists in clinical treatment could provide doctors with pharmaceutical information, optimize drug treatment programs, provide patients with pharmaceutical services, ensure the safety and effectiveness of medication, and play a positive role in promoting clinical rational medication.

关 键 词：肝硬化 糖尿病性痛性神经病变 疼痛 药学监护 

分 类 号：R97[医药卫生—药品]